The United States generic injectables market reached nearly USD 15.07 billion in 2024 and is projected to grow at a CAGR of 7.00% to reach approximately USD 29.64 billion by 2034. Growth is driven by rising demand for cost-effective treatments, increased chronic disease burden, and hospital use of injectable generics. https://www.expertmarketresearch.com/reports/united-states-generic-injectables-market